Dexcom’s Senior US Medical Director, Tomas Walker, talks to Stacey in a wide-ranging interview. Walker addresses everything from the features of the new G6 system recently submitted to the FDA, changes to the way the adhesive is created (which may have ease skin issues for some) to the news that Dexcom has partnered with Lilly…
In October 2017, Animas announced it would exit the insulin pump business and discontinue the manufacturing and sale of Animas® Vibe® and OneTouch Ping® insulin pumps. Stacey talks to the company’s Chief Medical Officer Dr. Brian Levy about what happened, what customers need to know and the future of insulin pumping as a business. Read the…
Join the new Diabetes Connections Facebook Group! —– Learn about the Abbott Freestyle Libre, a Flash Glucose Monitoring System recently approved in the US. We talk to Dr. Chris Thomas, the director of biosensor technology for Abbott about what exactly the Libre is, how it works and who it’s for. Plus, Bigfoot Biomedical is now…
Can using a CGM help people with type 2 diabetes who don’t use insulin pumps? Tomas Walker is Dexcom’s Director of Clinical Projects. He shares the results of their new DIaMonD study (Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes). Of course we also cover issues relevant to the type 1 community; Stacey asks about CGM use and Medicare coverage, possible changes…
Lots of news from Dexcom recently! Stacey talks with retired Chief Technical Officer Jorge Valdes about the Apple Watch announcement and much more. (This interview took place just before the FDA approved Dexcom G5 for Android, but that news is covered in the episode). Dexcom/Android info & compatible devices CNBC article on Apple/Dexcom Stacey also…
Jason Gensler has the unique experience of being one of the longest users of one of the newest insulin pumps. He started in a pivotal trial of the Medtronic 670G two years ago and has been allowed to keep using it ever since. Jason shares his misgivings about going back to Medtronic; he had a…
This week, Ed Damiano talks about his Bionic Pancreas project. Using a pump called the iLet and a Dexcom CGM, the only information the Bionic Pancreas needs is the user’s body weight. It adapts to you, no need to figure out insulin to carb ratios or correction factors. The iLet will eventually come to market using…
Anthony Hightower has used Afrezza for the past two years. He credits it (along with a Toujeo, a newer basal insuin) with completely changing his T1D management. In addition to excellent numbers, Anthony shares what else Afrezza has to offer. He explains, he liked it so much, he went to work for Mannkind, the company…
Tom Brobson is JDRF’s National Director of Research Investment Opportunities. He was diagnosed with type 1 as an adult and has been involved personally in many artificial pancreas trials, the first of which had him hooked up to a computer in the hospital and not allowed to get up or go anywhere without a healthcare…
This week: OpenAPS, Looping, Happ – a bunch of weird sounding terms that are changing the way many manage diabetes. Tim Street has lived with type 1 for 28 years, he writes a blog called Diabettech. Tim talks about the DIY systems out there right now (he’s tried almost all of them) and about all…